Reshma Ramachandran, MD, MPP, MHS is a board-certified family physician and health services researcher. Her research focuses on the realignment of incentives for healthcare stakeholders including pharmaceutical companies, hospitals, and universities towards prioritizing equitable patient access to safe, effective health technologies. She co-directs the Yale Collaboration for Regulatory Rigor, Integrity, and Transparency, an interdisciplinary initiative that researches medical product evaluation, approval, and coverage towards advancing policies that improve patient outcomes. Prior to this role, Reshma worked as research faculty as part of the Innovation + Design Enabling Access (IDEA) Initiative at the Johns Hopkins Bloomberg School of Public Health, where she focused on policies to address the global challenge of antimicrobial resistance and unaffordable access to prescription drugs. Dr. Ramachandran trained in both medicine at the Alpert Medical School at Brown University and in public policy at the Harvard Kennedy School of Government. She completed her family medicine residency at Kaiser Permanente Los Angeles Medical Center and health services research and policy fellowship at the National Clinician Scholars Program at Yale. Previously, she served as the first PharmFree Fellow with the American Medical Student Association focused on removing the undue influence of pharmaceutical companies on prescribing behavior and medical education. She currently chairs the Doctors for America FDA Task Force. She also is the Board President of Universities Allied for Essential Medicines (UAEM) North America.
Education & Training
- MHSYale School of Medicine (2022)
- MPPHarvard Kennedy School, International Trade and Finance (2015)
- MDAlpert Medical School at Brown University (2015)
- ScBBrown University, Physics (2009)
- Board CertificationAB of Family Medicine, Family Medicine (2020)